Axogen, Inc. Reports 2024 Fourth Quarter and Full-Year Financial Results
Provided By GlobeNewswire
Last update: Feb 25, 2025
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2024.
Read more at globenewswire.com
